What amount sold does Potrero Medical, Inc. report in Form D filings?

The latest linked filings report $82.7M sold across 8 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Potrero Medical, Inc.'s most recent SEC filing?

Potrero Medical, Inc.'s most recent Form D filing was on 2026-05-29.

How many investors does Potrero Medical, Inc. have?

The most recent Form D filing lists 56 investor(s).

What type of securities does Potrero Medical, Inc. offer?

Potrero Medical, Inc.'s SEC Form D filings indicate equity offerings.

Potrero Medical, Inc.

CIK: 0001609048·Biotechnology·HAYWARD, CA·Corporation

Reported Sold

$82,713,026

Total Filings

Identified Offerings

Last Filed

May 29, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

May 29, 2026Form D — New notice

Reported sold: $6,500,000 · Target: $6,500,000

Rule 506(c)·56 investors

Sep 2, 2025Form D — New notice

Reported sold: $2,278,241 · Target: $5,500,000

Rule 506(b)·29 investors

Oct 31, 2024Form D — New notice

Reported sold: $3,200,000 · Target: $12,000,000

Rule 506(b)·6 investors

Apr 10, 2023Form D — New notice

Reported sold: $17,747,111 · Target: $24,626,726

Rule 506(b)·99 investors

Oct 29, 2019Form D/A — Amendment

Reported sold: $17,185,962 · Target: $19,999,999

Rule 506(b)·26 investors

Changed: Reported amount sold, Offering target, Reported investors

Jul 12, 2019Form D — New notice

Reported sold: $11,742,968 · Target: $14,999,999

Rule 506(b)·20 investors

Jul 10, 2018Form D — New notice

Reported sold: $24,642,458 · Target: $31,332,845

Rule 506(b)·32 investors

Aug 7, 2017Form D/A — Amendment

Reported sold: $7,259,254 · Target: $12,061,558

Rule 506(b)·21 investors

Changed: Reported amount sold, Reported investors

Sep 13, 2016Form D — New notice

Reported sold: $4,839,258 · Target: $12,061,558

Rule 506(b)·14 investors

May 27, 2014Form D — New notice

Reported sold: $3,900,000 · Target: $3,900,000

Rule 506(c)·9 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$3,067,995

Amendment Rate

20%

Latest reported sold across 8 identified offerings

$82,713,026

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Daniel Burnett

Related Person

Appears on 4 filings

Alan Chesler

Related Person

Appears on 3 filings

Alan Chesler

Related Person

Appears on 3 filings

George Rapier

Related Person

Appears on 3 filings

Carter Meyer

Related Person

Appears on 3 filings

Daniel Burnett

Related Person

Appears on 3 filings

David Greenberg

Related Person

Appears on 3 filings

Joe Urban

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
May 29, 2026	New	$6,500,000	$6,500,000	56
Sep 2, 2025	New	$5,500,000	$2,278,241	29
Oct 31, 2024	New	$12,000,000	$3,200,000	6
Apr 10, 2023	New	$24,626,726	$17,747,111	99
Oct 29, 2019	Amendment	$19,999,999	$17,185,962	26
Jul 12, 2019	New	$14,999,999	$11,742,968	20
Jul 10, 2018	New	$31,332,845	$24,642,458	32
Aug 7, 2017	Amendment	$12,061,558	$7,259,254	21
Sep 13, 2016	New	$12,061,558	$4,839,258	14
May 27, 2014	New	$3,900,000	$3,900,000	9

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Tempest Therapeutics, Inc.

Biotechnology

Offering target: $7,500,000

Filed Oct 13, 2026